000			02250cam a2200325 a 4500
003			EG-GiCUC
008			150526s2014 ua d f m 000 0 eng d
040			_aEG-GiCUC _beng _cEG-GiCUC
041	0		_aeng
049			_aDeposite
097			_aM.Sc
099			_aCai01.11.18.M.Sc.2014.Ha.D
100	0		_aHamdy Mohamed Abdelaziz Ahmed
245	1	0	_aDetection of epstein - barr virus seropositivity in behçet{u2019}s disease / _cHamdy Mohamed Abdelaziz Ahmed ; Supervised Ahmed Abdelmoty Elnaggar , Badawy Mohamad Alkholy , Mohamed Ahmed Hussien
246	1	5	_aالكشف عن فيروس الايبشتاين بار فى مرضى بهجت
260			_aCairo : _bHamdy Mohamed Abdelaziz Ahmed , _c2014
300			_a198 P. : _bcharts ; _c25cm
502			_aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Internal Medicine
520			_aBehçet{u2019}s disease (BD) is a multisystem inflammatory disorder, BD etiology remains unknown, but epidemiologic findings suggest an autoimmune process that is triggered by an infectious or environmental agent in a genetically predisposed individual. Several viral agents including cytomegalovirus, epstein - barr virus, and varicella zoster virus, may also have some role. Try to assess the prevalence of EBV in behçet{u2019}s disease, and its relation to disease activity (assesed by BDCAF). 75 Egyptian patients with behçet{u2019}s disease as well as 75 (age and sex matched) apparently healthy Egyptians control. All our patients were subjected to full history taking and thorough clinical examination. Disesase activity of our patients was determined using the BDCAF. Laboratory investigations in the form of CBC, ESR, CRP, liver and kidney functions were done to all our patients. The levels of EBV IgM and IgG were measured by ELISA and also EBV Ig M and Ig G indices were calculated to all our patients and controls
530			_aIssued also as CD
653		4	_aBehçet
653		4	_aEtiolgy
653		4	_aOctivity
700	0		_aAhmed Abdelmoty Elnaggar , _eSupervisor
700	0		_aBadawy Mohamad Alkholy , _eSupervisor
700	0		_aMohamed Ahmed Hussien , _eSupervisor
905			_aNazla _eRevisor
905			_aSamia _eCataloger
942			_2ddc _cTH
999			_c51052 _d51052